Midbody Remnants as Signaling Centers in Cell Fate Determination and Tumorigenesis
DNA and Cell Biology · 01.07.2026 · 45 (7) · 317-326
DOI: 10.1177/10445498261448093 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift DNA and Cell Biology, online erschienen am 04.05.2026. Verfasst von Hongbin Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Engineering, Lanzhou University of Technology, Lanzhou, People's Republic of China. Hauptthemen laut MEDLINE: Signal Transduction, Carcinogenesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
During final cell division, the cleaved midbody is either released or asymmetrically retained as a midbody remnant (MBR). MBRs play critical roles in cell communication, signal transduction, and translation regulation, influencing cellular fate. Here, we synthesize their functions as RNA-processing granules, polarity regulators, and signaling platforms, emphasizing their role in primary cilia formation. In polarized epithelial cells, the MBR moves along the apical surface to the centrosome, delivering membrane components to permit ciliogenesis. In ductal carcinoma cells, MBR-localized Shc1-binding protein (SHCBP1) interacts with TBC1 domain family member 30 (TBC1D30 to antagonize Ras-related protein Rab-8 (Rab8) GTPase activity, blocking MBR-centrosome proximity and silencing ciliogenesis. Beyond ciliary regulation, MBRs integrate Wnt, PDGF, TGF- β , and genomic stability networks, acting as dynamic signaling hubs during cancer development. Regarding therapeutic strategies targeting MBRs, High SHCBP1 expression correlates with ciliary loss and poor prognosis in breast, pancreatic, and cholangiocarcinoma. Targeting the SHCBP1/Rab8 axis to restore ciliogenesis by reestablishing MBR-centrosome proximity offers a potential therapeutic strategy. In addition, secreted MBRs are enriched in signaling components and transcripts, serving as intercellular carriers of oncogenic cargoes and promising liquid biopsy biomarkers. In summary, by tracing MBRs from their postmitotic origin to their pathogenic roles, we highlight vulnerabilities within MBR regulatory networks and provide novel insights for cancer therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Science and Engineering, Lanzhou University of Technology, Lanzhou, People's Republic of China.
- Cuiying Biomedical Research Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, People's Republic of China.
- Gansu Provincial Center for Basic Research in Cancer Immunology, Lanzhou University, Lanzhou, People's Republic of China.
- The Department of Pain Treatment, Gansu Provincial Hospital of TCM, Lanzhou, People's Republic of China.
ORCID-Profile: Wengui Shi
Förderung
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Li, H., Ma, X., Liang, J., Xue, K., Shi, W., & Lang, W. (2026). Midbody Remnants as Signaling Centers in Cell Fate Determination and Tumorigenesis. DNA and Cell Biology, 45(7), 317-326. https://doi.org/10.1177/10445498261448093
Vancouver
Li H, Ma X, Liang J, Xue K, Shi W, Lang W. Midbody Remnants as Signaling Centers in Cell Fate Determination and Tumorigenesis. DNA and Cell Biology. 2026;45(7):317-326. doi:10.1177/10445498261448093
BibTeX
@article{Li2026,
author = {Li, Hongbin and Ma, Xiaoli and Liang, Jing and Xue, Kai and Shi, Wengui and Lang, Wanying},
title = {Midbody Remnants as Signaling Centers in Cell Fate Determination and Tumorigenesis},
journal = {DNA and Cell Biology},
year = {2026},
volume = {45},
number = {7},
pages = {317--326},
doi = {10.1177/10445498261448093}
}
EUVIMED